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We read with interest the article of Dr. Beshay and
colleagues [1], concerning a case of bilateral typical
carcinoid tumors. We agree that bilateral lesions are
rare entities but, probably, not exceptional. We had a
similar experience in a patient operated on in 1999. A
60-year-old man was admitted after the discovery of
two bilateral well-defined lung nodules. After a careful
staging to exclude extrathoracic deposits, two staged
(1 month) thoracotomies were planned and a lingulect-
omy and a right upper lobectomy with radical lymph
nodes dissection (RLND) were done, respectively.
According to the last WHO classification, the left-
sided tumor was an atypical carcinoid tumor (pT1, pN1)
with solid and spindle cell features and a proliferative
activity (Ki-67) of 16%, whereas the contralateral one
was a typical carcinoid tumor (pT1, pN0) with solid to
trabecular histological appearance and a Ki-67 of 3.5%.
The immunohistochemical characterization for neuro-
endocrine differentiation markers and several respiratory
tract-related hormones revealed no remarkable differ-
ences between the two lesions. All these morphological
considerations support the view that the two tumors are
best interpretable as being independent of each other in
the form of synchronous, bilateral neoplasms. In fact,
although the atypical lesion showed focal vascular
invasion and peribronchial lymph node metastases, it
is unlikely that a typical carcinoid may originate from
an atypical lesion inasmuch as tumors usually progress
in their malignancy.
Both postoperative courses were uneventful and the
patient is alive and disease-free 3 years after the last
operation.
From 1996 until now, we have operated on 63 patients
with carcinoid tumors, and the present case represents 1.6%
of the overall series.
Two aspects of the paper deserve attention: the lack
of consensus about the type of lung resection and the
use of positron emission tomography (PET) scan in
these tumors.
Even though there is no consensus about the type of
pulmonary resection, we believe that an anatomical
resection associated with RLND should be used in all
patients. All patients in our series underwent anatomical
resection with RLND and 27% of cases showed lymph node
metastases (14% N1 and 13% N2). These percentages
increase in atypical form (50%, 11/22: N1 22.7%, N2
27.3%) with respect to the typical one (14.6%, 4/41: N1
9.7%, N2 4.9%). Taking into account that surgery is the only
therapeutic option to cure a patient with lung carcinoid,
anatomical resection associated with RLND should be
considered the gold standard treatment, being wedge or
segmental resection without lymph node dissection at risk of
developing recurrence.
It has been suggested that PET scanning could be
less effective in low-grade malignancies, and its use
could be useless in carcinoid tumors. In the last 2 years
25 consecutive patients of our series underwent PET
scan before operation. PET was positive in 84% of
these patients (93% in atypical vs. 73% in typical
carcinoid tumors).
In conclusion, we believe that pulmonary carcinoid
tumors constitute low-grade malignant disease needing
anatomical resection and RLND for their cure, and PET
scan could be useful in the preoperative staging.
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